Literature DB >> 34970798

Review of human genetic and clinical studies directly relevant to GnRH signalling.

Stephanie B Seminara1, A Kemal Topaloglu2.   

Abstract

GnRH is the pivotal hormone in controlling the hypothalamic-pituitary gonadal (HPG) axis in humans and other mammalian species. GnRH function is influenced by a multitude of known and still unknown environmental and genetic factors. Molecular genetic studies on human families with hypogonadotropic hypogonadism over the past two decades have been instrumental in delineating the kisspeptin and neurokinin B signalling, which integrally modulates GnRH release from the hypothalamus. The identification of kisspeptin and neurokinin B ligand-receptor gene pair mutations in patients with absent puberty have paved the way to a greater understanding of the central regulation of the HPG cascade. In this article, we aim to review the literature on the genetic and clinical aspects of GnRH and its receptor, as well as the two ligand-receptor sets directly pertinent to the function of GnRH hormone signalling, kisspeptin/ kisspeptin receptor and NKB/NK3R.
© 2021 British Society for Neuroendocrinology.

Entities:  

Keywords:  GnRH; hypogonadotropic hypogonadism; kisspeptin; neurokinins; puberty

Mesh:

Substances:

Year:  2021        PMID: 34970798      PMCID: PMC9299506          DOI: 10.1111/jne.13080

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.870


  123 in total

1.  Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54.

Authors:  J Carl Pallais; Yousef Bo-Abbas; Nelly Pitteloud; William F Crowley; Stephanie B Seminara
Journal:  Mol Cell Endocrinol       Date:  2006-06-06       Impact factor: 4.102

Review 2.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.

Authors:  Jessica X Chong; Kati J Buckingham; Shalini N Jhangiani; Corinne Boehm; Nara Sobreira; Joshua D Smith; Tanya M Harrell; Margaret J McMillin; Wojciech Wiszniewski; Tomasz Gambin; Zeynep H Coban Akdemir; Kimberly Doheny; Alan F Scott; Dimitri Avramopoulos; Aravinda Chakravarti; Julie Hoover-Fong; Debra Mathews; P Dane Witmer; Hua Ling; Kurt Hetrick; Lee Watkins; Karynne E Patterson; Frederic Reinier; Elizabeth Blue; Donna Muzny; Martin Kircher; Kaya Bilguvar; Francesc López-Giráldez; V Reid Sutton; Holly K Tabor; Suzanne M Leal; Murat Gunel; Shrikant Mane; Richard A Gibbs; Eric Boerwinkle; Ada Hamosh; Jay Shendure; James R Lupski; Richard P Lifton; David Valle; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-07-09       Impact factor: 11.025

Review 3.  A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant.

Authors:  Melvin M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

4.  When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR).

Authors:  Elena Gianetti; Janet E Hall; Margaret G Au; Ursula B Kaiser; Richard Quinton; Jane A Stewart; Daniel L Metzger; Nelly Pitteloud; Veronica Mericq; Paulina M Merino; Lynne L Levitsky; Louise Izatt; Mariarosaria Lang-Muritano; Victor Y Fujimoto; Robert G Dluhy; Matthew L Chase; William F Crowley; Lacey Plummer; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

5.  Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates.

Authors:  Muhammad Shahab; Claudio Mastronardi; Stephanie B Seminara; William F Crowley; Sergio R Ojeda; Tony M Plant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

6.  Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.

Authors:  David F Archer; Elizabeth A Stewart; Rita I Jain; Robert A Feldman; Andrea S Lukes; Janine D North; Ahmed M Soliman; Jingjing Gao; Juki W Ng; Kristof Chwalisz
Journal:  Fertil Steril       Date:  2017-06-01       Impact factor: 7.329

7.  Complete Idiopathic Hypogonadotropic Hypogonadism due to Homozygous GNRH1 Mutations in the Mutational Hot Spots in the Region Encoding the Decapeptide.

Authors:  Eda Mengen; Selma Tunc; L Damla Kotan; Ozlem Nalbantoglu; Korcan Demir; Fatih Gurbuz; Ihsan Turan; Gül Seker; Bilgin Yuksel; A Kemal Topaloglu
Journal:  Horm Res Paediatr       Date:  2015-11-24       Impact factor: 2.852

8.  Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation.

Authors:  Antonia K Roseweir; Alexander S Kauffman; Jeremy T Smith; Kathryn A Guerriero; Kevin Morgan; Justyna Pielecka-Fortuna; Rafael Pineda; Michelle L Gottsch; Manuel Tena-Sempere; Suzanne M Moenter; Ei Terasawa; Iain J Clarke; Robert A Steiner; Robert P Millar
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

9.  Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.

Authors:  Graeme L Fraser; Barbara Obermayer-Pietsch; Joop Laven; Georg Griesinger; Axelle Pintiaux; Dirk Timmerman; Bart C J M Fauser; Christopher Lademacher; Jean Combalbert; Hamid R Hoveyda; Steven Ramael
Journal:  J Clin Endocrinol Metab       Date:  2021-05-17       Impact factor: 5.958

10.  Effects of neurokinin B administration on reproductive hormone secretion in healthy men and women.

Authors:  Channa N Jayasena; Alexander N Comninos; Akila De Silva; Ali Abbara; Johannes D Veldhuis; Gurjinder M K Nijher; Zainab Ganiyu-Dada; Meriel Vaal; Gordon Stamp; Mohammad A Ghatei; Stephen R Bloom; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.